tiprankstipranks
Prothena (PRTA)
NASDAQ:PRTA

Prothena (PRTA) Technical Analysis

540 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Prothena’s (PRTA) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting Prothena is a Sell.
Prothena’s (PRTA) 20-Day exponential moving average is 20.80, while Prothena’s (PRTA) share price is $20.39, making it a Sell.
Prothena’s (PRTA) 50-Day exponential moving average is 21.73, while Prothena’s (PRTA) share price is $20.39, making it a Sell.

Prothena (PRTA) Pivot Points

Jul 03, 2024, 05:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.47
19.78
20.21
20.52
20.95
21.26
21.69
Fibonacci
19.78
20.06
20.24
20.52
20.80
20.98
21.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prothena (PRTA) Moving Averages

Jul 03, 2024, 05:28 AM
Period
Simple
Exponential
MA5
20.48Buy
20.55Sell
MA10
20.50Sell
20.62Sell
MA20
20.97Sell
20.80Sell
MA50
21.25Sell
21.73Sell
MA100
23.68Sell
24.80Sell
MA200
31.15Sell
33.31Sell
Prothena’s (PRTA) 10-Day exponential moving average is 20.62, while Prothena’s (PRTA) share price is $20.39, making it a Sell.
Prothena’s (PRTA) 100-Day exponential moving average is 24.80, while Prothena’s (PRTA) share price is $20.39, making it a Sell.
Prothena’s (PRTA) stock price is $20.39 and Prothena’s (PRTA) 50-day simple moving average is 21.25, creating a Sell signal.
Prothena’s (PRTA) stock price is $20.39 and Prothena’s (PRTA) 100-day simple moving average is 23.68, creating a Sell signal.
Prothena’s (PRTA) stock price is $20.39 and Prothena’s (PRTA) 200-day simple moving average is 31.15, creating a Sell signal.

Prothena (PRTA) Technical Indicators

Jul 03, 2024, 05:28 AM
Name
Value
Implied Action
RSI (14)
46.67
Neutral
STOCH (9,6)
49.47
Neutral
STOCHRSI (14)
49.47
Neutral
MACD (12,26)
-0.28
Sell
ADX (14)
10.43
Buy
Williams %R
-52.39
Buy
CCI (14)
-33.19
Neutral
ATR (14)
1.11
-
Ultimate Oscillator
50.14
Neutral
ROC
-2.66
Sell
Prothena’s (PRTA) Relative Strength Index (RSI) is 46.67, creating a Neutral signal.
Prothena’s (PRTA) Trend Strength Indicator (ADX) is 10.43, creating a Buy signal.
Prothena’s (PRTA) Commodity Channel Index (CCI) is -33.19, creating a Neutral signal.
Prothena’s (PRTA) Price Rate of Change (ROC) is -2.66, creating a Sell signal.

FAQ

Is PRTA a Buy, Hold, or Sell?
Based on PRTA’s technical indicators, PRTA is a Sell.
    What is PRTA’s RSI (14)?
    PRTA’s RSI (14) is 46.67, which suggests PRTA is a Neutral.
      What is PRTA’s MACD?
      PRTA’s MACD is -0.28, which suggests PRTA is a Sell.
        What is PRTA’s 5-day moving average?
        PRTA’s 5-day moving average is 20.48, which suggests PRTA is a Buy.
          What is PRTA’s 20-day moving average?
          PRTA 20-day moving average is 20.97, which suggests PRTA is a Sell.
            What is PRTA’s 50-day moving average?
            PRTA’s 50-day moving average is 21.25, which suggests PRTA is a Sell.
              What is PRTA’s 200-day moving average?
              PRTA’s 200-day moving average is 31.15, which suggests PRTA is a Sell.
                What is PRTA’s Williams % R (14)?
                PRTA’s Williams % R (14) is -52.39, which suggests PRTA is a Buy.
                  What is PRTA’s CCI (14)?
                  PRTA’s CCI (14) is -33.19, which suggests PRTA is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis